James L. Kelley
James L. Kelley publishes mostly in Organic Chemistry, Molecular Biology and Infectious Diseases, on topics such as HIV/AIDS drug development and treatment, Synthesis and Characterization of Heterocyclic Compounds and Synthesis and Biological Evaluation.
- World rank
- #7,478,839 of 7,710,434 ranked researchers
- Rank in United States
- #1,611,595 of 1,627,098
- Works
- 148
- Citations
- 1.6k
- Citations per work
- 10.5
What does James L. Kelley research?
James L. Kelley's work is mostly in Chemistry (30%), Biochemistry, Genetics and Molecular Biology (16%), Medicine (13%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else5738.4%
- Physical Sciences4429.5%
- Chemistry4429.5%
- Life Sciences2416.3%
- Health Sciences2013.3%
- Medicine2013.3%
- Social Sciences42.5%
- Psychology42.5%
- 1Organic Chemistry30% of their works
- 2Molecular Biology14% of their works
- 3Infectious Diseases7% of their works
- 4Epidemiology6% of their works
- 5Physiology2% of their works
- 6Social Psychology2% of their works
Research topics
- HIV/AIDS drug development and treatment
- Synthesis and Characterization of Heterocyclic Compounds
- Synthesis and Biological Evaluation
- Biochemical and Molecular Research
- Synthesis and Reactivity of Heterocycles
- Phenothiazines and Benzothiazines Synthesis and Activities
- Adenosine and Purinergic Signaling
- Chemical Synthesis and Analysis
Which keywords describe James L. Kelley's research?
The keywords of their largest research topics: Synthesis, Biological Evaluation, Molecular Docking, Antimicrobial Activity, Heterocyclic Compounds, Anticancer, Antimicrobial and Drug Discovery.
- Peptide Synthesis
- Purinergic Signalling
- Phenothiazines
- Nucleotide Metabolism
- Enzyme Regulation
- Quinoxaline
- Triazines
- HIV Infection
- Drug Discovery
- Anticancer
- Antimicrobial Activity
- Biological Evaluation
- Synthesis
- Molecular Docking
- Heterocyclic Compounds
- Antimicrobial
- Antiretroviral Therapy
- Scaffold
- Derivatives
- Bioactivity
- Indolizines
- Biological Activities
- Adenosine Receptors
- Foldamers
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 24 words, with their numbers
- Synthesis764 topics
- Biological Evaluation623 topics
- Molecular Docking412 topics
- Antimicrobial Activity402 topics
- Heterocyclic Compounds402 topics
- Anticancer362 topics
- Antimicrobial362 topics
- Drug Discovery312 topics
- Antiretroviral Therapy271 topic
- HIV Infection271 topic
- Scaffold221 topic
- Triazines221 topic
- Derivatives211 topic
- Quinoxaline211 topic
- Bioactivity191 topic
- Enzyme Regulation191 topic
- Indolizines191 topic
- Nucleotide Metabolism191 topic
- Biological Activities141 topic
- Phenothiazines141 topic
- Adenosine Receptors101 topic
- Purinergic Signalling101 topic
- Foldamers91 topic
- Peptide Synthesis91 topic
Where does James L. Kelley work?
James L. Kelley's main affiliation in the publication record is Burroughs Wellcome Fund, United States.
How many publications and citations does James L. Kelley have?
OpenAlex counts 148 works and 1,561 citations for James L. Kelley, an h-index of 24, ranking #7,478,839 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about James L. Kelley. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.